Ablative Solutions Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 28
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $81M
Latest Deal Amount
  • Investors
  • 9

Ablative Solutions General Information

Description

Developer of a novel approach designed to address the significant unmet clinical need for systemic hypertension. The company's approach is a new catheter-based approach for percutaneous delivery of diagnostic and therapeutic agents into the area surrounding the peripheral blood vessels, enabling clinicians to alter the overactive signaling process and reduce patients' blood pressure.

Contact Information

Website
www.ablativesolutions.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 2479 East Bayshore Road
  • Kalamazoo, MI
  • United States
+1 (650) 000-0000

Ablative Solutions Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ablative Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 03-Jan-2019 $81M 00000 00000 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series C) 01-Mar-2017 000.00 000.00 0000 Completed Clinical Trials - Phase 3
3. Early Stage VC (Series B) 12-Jan-2015 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 19-Jun-2012 $5.37M $12.3M 000.00 Completed Startup
1. Early Stage VC 10-Feb-2012 $6.92M $6.92M Completed Startup
To view Ablative Solutions’s complete valuation and funding history, request access »

Ablative Solutions Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D2 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series D1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00 00.0 00.00 00 00.0 00.000
Series B 2,805,392 $0.001000 8% $5.57 $8.36 1x $5.57 5.07%
Series A 1,287,757 $0.001000 8% $3.85 $5.78 1x $2.3 3.96%
To view Ablative Solutions’s complete cap table history, request access »

Ablative Solutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a novel approach designed to address the significant unmet clinical need for systemic hypertension. The com
Surgical Devices
Kalamazoo, MI
28 As of 2020
00000
0000 0000-00-00
00000000000 00000

00000 00

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
00000000000 0000000
Palo Alto, CA
00 As of 0000
000.00
000000&0 000.00

00000 00

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
00000000 0000000
Sunnyvale, CA
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ablative Solutions Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recor Medical Formerly VC-backed Palo Alto, CA 00 000.00 000000&0 000.00
00000 0000000 Formerly VC-backed Sunnyvale, CA 00 000.00 000000&0 000.00
000000 00000000 Angel-Backed Menlo Park, CA 0 00.00 0000000000 00.00
000000000 Corporation Minneapolis, MN 00000 00000000
To view Ablative Solutions’s complete competitors history, request access »

Ablative Solutions Executive Team (12)

Name Title Board Seat Contact Info
Kathryn Rumrill President, Chief Executive Officer & Board Member
Tim Fischell MD Co-Founder & Chief Medical Officer
Lisa Mastromattei Vice President of Finance & Administration
Nicole Haratani Vice President of Global Clinical, Regulatory Affairs and Quality
David Fischell Ph.D Co-Founder & Board Member
You’re viewing 5 of 12 executive team members. Get the full list »

Ablative Solutions Board Members (11)

Name Representing Role Since
Andrew Tochterman Ablative Solutions Board Member 000 0000
Dale Grogan Michigan Accelerator Fund 1 Board Member 000 0000
David Fischell Ph.D Self Co-Founder & Board Member 000 0000
Geoff Pardo Gilde Healthcare Partners Board Member 000 0000
Kathryn Rumrill Ablative Solutions President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Ablative Solutions Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ablative Solutions Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Gilde Healthcare Partners Venture Capital Minority 000 0000 000000 0
Trout Creek Ventures Venture Capital Minority 000 0000 000000 0
Dempsey Ventures PE/Buyout Minority 000 0000 000000 0
GlobalLink1 Capital PE/Buyout Minority 000 0000 000000 0
BioStar Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial